The ketogenic diet is low in sugar and carbohydrate. It has benefits of lowering high blood glucose levels. A new study of US scientists has reported a significant impact of the ketogenic diet in restricting cancer growth. 

The key finding is that the ketogenic diet alone has some tumor-growth inhibitory effect in cell cancer. The diet can be combined with chemotherapy and SGLT2 inhibitor treatment. By reducing blood glucose, it reduces levels of insulin and insulin-like growth factor, which are important drivers of cancer cells.

The ketogenic diet prevents glucose in the blood from being reabsorbed by the kidney which is more effective. These results show the importance of a ketogenic diet to suppress tumor growth.